CONFERENCES

      International Society for Quality of Life Research

      ISOQOL is an annual event that focuses on the latest advances in the science of quality of life (QOL) and patient-reported outcomes (PRO), with topics ranging from best practices to educational support. The conference is aimed at a global community of researchers, clinicians, health care professionals, industry professionals, consultants, and patient research partners advancing health-related quality of life research (HRQL), and provides a forum for sharing knowledge and collaborating in fields where the patient perspective is integral to health research, care and policy.

      ISOQOL 2021

      Date

      Oct 12, 2021 - Oct 28, 2021

      Location

      Online

      This conference, which has for theme "Making valid decisions: Learning from Patient Reported Outcomes", includes over 250 oral briefs and poster presentations. 

      ISOQOL 2020

      Date

      Oct 19, 2020 - Oct 23, 2020

      Location

      Online

       The 2020 conference focuses on important developments in collecting, analyzing, interpreting and disseminating patient-centered outcomes data, with an emphasis on A Vision for the Future of Outcomes Measurement and Quality of Life Research.

      See related presentations

      ISOQOL 2018

      Date

      Oct 24, 2018 - Oct 27, 2018

      Location

      Dublin, Ireland

      Attended by a record-breaking 612 registrants from a variety of fields and career stages, this conference's theme is “Patient Reported Outcomes in the digital age: New frontiers in research, policy and practice".

      See related posters

      PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts in support of its smoke-free product portfolio. This site is a global site for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not advertising or marketing, nor is it directed at any specific market. It is not intended for use by consumers. New tobacco products sold in the United States are subject to FDA regulation; therefore the content of this site is not intended to make, and nor should it be construed as making, any product related claims in the United States without proper FDA authorization. ​
      ​
      Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. All of our RRPs are smoke-free products that deliver nicotine with far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.